Brain organoids are promising tools for disease modeling and drug development. For proper neuronal network formation excitatory and inhibitory neurons as well as glia need to co-develop. Here, we report the directed self-organization of human induced pluripotent stem cells in a collagen hydrogel towards a highly interconnected neuronal network at a macroscale tissue format. Bioengineered Neuronal Organoids (BENOs) comprise interconnected excitatory and inhibitory neurons with supportive astrocytes and oligodendrocytes. Giant depolarizing potential (GDP)-like events observed in early BENO cultures mimic early network activity of the fetal brain. The observed GABA polarity switch and reduced GDPs in >40 day BENO indicate progressive neuronal network maturation. BENOs demonstrate expedited complex network burst development after two months and evidence for long-term potentiation. The similarity of structural and functional properties to the fetal brain may allow for the application of BENOs in studies of neuronal plasticity and modeling of disease.
Brain organoids recapitulate several aspects of cortical development in vitro. Applications in disease modeling1,2 and drug screening3 have been demonstrated. Patterning protocols have been developed to generate fore-, mid-, and ventral-brain organoids4,5,6. Although complex anatomical layering and activity of individual neurons has been elegantly demonstrated7,8, little is known about network function9 and plasticity of established brain organoid models.
During early corticogenesis, bursts of action potentials cause spreading of giant waves of calcium influxes through the developing cortex10. This synchronized activity, described as giant depolarizing potentials (GDPs), depends both on excitatory glutamate and GABA inputs11. GDPs are initiated by so called hub or pioneer neurons, which are known to have long axons and to connect with many other neurons in parallel12. In humans, GABA and glutamate sensitive GDPs have been observed in fetal cortex13,14,15.
A number of studies have shown the importance of supporting glia for neuronal network function and plasticity16. Moreover, a recent study on network function of brain organoids elegantly demonstrated the importance of inhibitory neurons for complex network development, both coinciding after 6 months of differentiation9.
Aiming to recapitulate human brain network function, we develop Bioengineered Neuronal Organoids (BENOs) from human-induced pluripotent stem cells (iPSCs). BENOs consist of functionally integrated excitatory (glutamatergic) and inhibitory (GABAergic) neurons as well as supporting glia. Collectively, this cellular diversity demonstrates neuronal network function classically found in the developing brain, such as GDP and a GABA polarity switch, and within the more matured human brain, such as neuronal plasticity.
BENO generation protocol
BENOs are generated from human iPSCs dispersed in a collagen type I environment and are subjected to a staged directed differentiation and maturation protocol. The introduced BENO protocol differs from previously established neuronal organoid cultures1,2,3,5,6,8 by (1) a 1-step culture, directed differentiation approach and (2) the use of fully defined components, such as a pluripotent stem cell source, collagen, small molecules, and growth factors. We initially tested five different directed differentiation protocols (Fig. 1a, Supplementary Fig. 1a–c), starting with a 10 day induction of neuroectodermal commitment in the presence of SB/noggin (dual smad inhibition) and retinoic acid (RA) followed by extended culture in Neurobasal medium (protocol 1); further addition of FGF-2 on culture days 10–15 to enhance neuronal progenitor growth17 (protocol 2), TGFβ1 on culture days 10–28 to enhance gliogenesis18 (protocol 3), and DAPT from culture days 15–28 to enhance neuronal differentiation19 (protocol 4) were tested. Finally, a combination of SB/Noggin/RA (days 0–10), FGF-2 (days 10-15), TGFβ1 (days 10-28), and DAPT (days 15-28) was investigated (protocol 5) and found to optimally induce neuro- and gliogenesis. qPCR analyses confirmed a rapid loss of pluripotency (POU5F1; Supplementary Fig. 2) with transcripts related to neurogenesis (PAX6, MAP2, GRIN1, GABBR2) being upregulated from culture day 15 onwards in protocols 4 and 5 (Fig. 1b, Supplementary Fig. 2). This was confirmed by immunostaining for neuronal markers (NF-H, SYP, MAP2) (Fig. 1c). While both protocols supported neurogenesis, protocol 5 additionally enhanced gliogenesis (Fig. 1b–d, Supplementary Fig. 1d) and increased reproducibility as indicated by robust spontaneous calcium activity (Fig. 1e) in morphologically highly uniform BENOs at all investigated time points (Supplementary Fig. 1e).
Transcriptome profiling during BENO development
To gain insight into the cell population dynamics during BENO formation, we performed a time-course RNAseq analysis from samples obtained on culture days 0, 3, 8, 15, 28, 40, 50 and 60 (two independent experiments, n = 3–6 organoid/time point). Principal component analyses and correlation heat maps provided evidence for the recapitulation of distinct developmental stages in BENOs on culture days d-1 to d3, d3–d8, d8–d15, d28–d40, and d50–d60 (Supplementary Fig. 3a, b). Notably, BENOs presented a low inter-organoid variability at the different sampling time points. A prominent expression of pluripotency markers characterized the cell population between d-1 and 3. On d3–8, BENOs were enriched in early neuroectodermal cell markers, on d8–15 in neuronal progenitor cell (NPC) markers, on d28–40 in neuronal markers, and on d50–60 in glia markers (Fig. 2a). Between d28–60, markers expressed by distinct types of neurons (glutamatergic, GABAergic, catecholaminergic), their respective receptors as well as transcripts related to synaptic transmission and ion channels were abundantly identified (Fig. 2b, c). In line with this observation, gene ontology (GO) analyses in d15 vs. d40 BENOs indicated the presence of components, which are essential for neuronal network function and plasticity (Supplementary Data 1). Endodermal and mesodermal markers showed minimal expression (5–10 FPKM) compared to neuronal markers (100–1000 FPKM; Supplementary Fig. 3c) detailing that BENOs contained negligible non-ectodermal components. From d50, transcripts indicating the development of outer radial glia were strongly upregulated along with hyaluronic acid synthase, hyaluronan, proteoglycan link protein 1, lumicon, and collagen I, a subset of proteins which recently have been shown to be involved in the folding of embryonic human cortex20 (Supplementary Fig. 3d). At the same time, the high expression of astrocyte markers was accompanied by extracellular matrix components, suggesting the presence of functional astrocytes (Supplementary Fig. 3e).
BENO cellular composition
Next, we utilized whole-mount immunofluorescence (WmIF) analyses to investigate the spatiotemporal development of multiple cell populations in BENOs. On d15, we observed concentric expansion of highly proliferative PAX6+ Ki67+ NPCs (Fig. 3a). On d40, evidence for the development of a subventricular zone (TBR2+ cells) adjacent to an outer self-organizing cortical plate (CTIP2+ cells) was obtained (Fig. 3b). On d40, BENOs contained excitatory catecholaminergic (TH+) and glutamatergic (vGLUT+) neurons as well as the respective target cells expressing typical cortical glutamatergic receptors such as GLUR1 (Fig. 3c, d, Supplementary Fig. 4). In parallel, an extensive network of GABA+ cells as well as GABBR2+ cells were present in d40 BENOs (Fig. 3e). On d60, in line with the transcriptome data, BENOs were enriched with astrocytes marked by GFAP/S100beta expression (Fig. 3f), while first oligodendrocyte progenitors (OLIG2+ cells) appeared (Supplementary Fig. 5). By a further extension of BENO culture for up to 150 days, we observed OLIG2+ cells as well as MBP and CNP expression and the presence of the first myelinated axons after 90 days in culture (Fig. 3g). By day d150 the number of CNP+ OLIG2+ cells as well as myelinated axons increased markedly (Fig. 3h, Supplementary Fig. 5b–f).
GABA- and glutamate-dependent GDP-like events in BENO
We next confirmed the presence of functional neurons by whole-cell patch-clamp recordings of BENO (d35-d65) cultures, showing tetradotoxin (TTX)-sensitive excitatory postsynaptic potentials (TTX, 1 nM) and functional sodium and potassium channels (Supplementary Fig. 6a). To further characterize neuronal network development, we analyzed spontaneous and stimulation-induced calcium activity in BENOs between culture day 20 and 98. Interestingly, the BENO network analysis showed pronounced differences during BENO development, indicating three distinct stages of network development: (1) early stage (ES) prior to d25, (2) intermediate stage (IS) between d25–d40, and (3) late stage (LS) d40 and onwards.
During the ES, calcium signal analysis demonstrated a high abundance of neurons with TTX-sensitive spontaneous activity (Fig. 4a, Supplementary Fig. 6b). In the next couple of days, the appearance of highly organized, spontaneous, synchronous calcium bursts, resembling GDPs, suggested early network formation similar to processes identified in the developing brain (Fig. 4b, Supplementary Movie 1). At this stage, local electrical stimulation (single pulses, 300 µA) induced TTX-sensitive synchronized calcium bursts at up to 200 µm distance from the electrode, but failed to propagate to remote regions. In contrast, high frequency stimulations (HFS) in ES BENOs evoked GDP-like events throughout the organoid (Supplementary Fig. 6c).
During the IS, spontaneous GDP-like event frequency was the highest (3.6 ± 0.6 events per 5 min, n = 8; Fig. 4c, Supplementary Movies 2 and 3). To understand which neurotransmitter contributed to network synchronization, we measured the spontaneous activity of BENOs in the presence and absence of selective inhibitors against GABAergic and glutamatergic receptors. GABAergic inhibition, by the non-selective antagonist for GABA-A/-C, Picrotoxin (PTX: 58 µM) and the selective antagonists for GABA-B, Saclofen (330 µM) reduced the occurrence of GDP-like events (n = 4 organoids; Fig. 4d, e, Supplementary Fig. 6d). The reduced activity suggested an existence of excitatory presynaptic GABA signals, which have been recognized to trigger GDPs in the developing brain12. Inhibition of the glutamatergic network, by the combination of the non-competitive NMDA antagonist, Dizocilpine (MK-801: 0.2 µM) and the competitive AMPA/kainate receptor antagonist, Cyanquixaline (CNQX: 15 µM), strongly decreased the frequency of synchronous calcium activity (n = 3 organoids; Fig. 4d, f, Supplementary Fig. 6e). These data show that both glutamatergic and GABAergic neurotransmission contributes to the observed GDP-like events.
At the LS, no spontaneous GDP-like events could be recorded (Fig. 4c). To investigate whether the absence of GDPs in day 40 BENOs indicated further maturation of the neuronal networks, we again applied electrical point stimulation. Single pulses of low intensity (100 µA) evoked TTX-sensitive calcium activity at up to 1 mm distance to the stimulation electrode (Fig. 4g). Continuous neuronal network development was demonstrated by a further increase in signal propagation up to 2 mm after stimulation from the same location (n = 6 BENOs tested); in some cases, propagation between two BENOs after fusion could be observed (Fig. 4g).
Given that, GDP-like events were suppressed in ES and IS stage BENOs by GABAergic and glutamatergic inhibitors, we assessed whether these neurotransmitters can induce GDP-like events in more mature LS stage BENOs. We found that 10 and 100 µM glutamate could evoke GDP-like events in ES, IS, and LS BENOs (n = 3 organoids and 14 ROIs/group; Fig. 4h). In contrast, 10 and 100 µM GABA-evoked GDP-like events only in ES and IS BENOs, but not LS BENOs. These data suggested a developmental switch of GABA from excitatory to inhibitory around differentiation day 40 (n = 3 organoids and 14 ROIs/group; Fig. 4h). To verify the inhibitory role of GABA in LS BENOs we measured spontaneous and electrically induced calcium activity under GABA inhibition. GABA inhibition by PTX increased global calcium activity in intensity as well as in frequency, resulting in repetitive synchronized activity reminiscent of epileptic events (n = 3 organoids; Fig. 4i). In line with this observation, stimulation-induced calcium release was intensified under GABA inhibition, while glutamatergic network inhibition (CNQX/MK-801) resulted in a marked decrease of signal intensity (n = 3 organoids; Fig. 4j). The reduced incidence of GDPs and the characteristic shift from excitatory to inhibitory GABA activity suggest LS BENOs undergo similar staged developmental maturation as observed in the human brain.
BENOs develop complex network bursts
Spatiotemporal neuronal network organization was assessed in d20 BENOs (n = 4) over 40 days using multi-electrode arrays (MEAs) to monitor individual network activity (Fig. 5a). ES-BENOs showed sparse electrical activity, which slowly organized in neuronal bursts as well as synchronous activity between neurons in different areas of the organoids, known as network bursts (NB). During the IS, the number of individual bursts and NB increased; in LS BENOs bursts organized in complex synchronous events (Fig. 5b, Supplementary Fig. 7). A heat map of spike amplitude (µV) and spike rate (spike/sec) revealed the regional connectivity of the neurons (Fig. 5c). The mean firing rate and the number of active electrodes significantly increased during the different developmental network stages (LS: 1.5 ± 0.18 Hz and 33 ± 2%; Fig. 5d, Supplementary Fig. 8a). Moreover, there was a dramatic increase in synchronous firing in different regions of the BENO depicted by the area under the normalized cross-correlation graph (ES: 0, IS: 0.04 ± 0.01, LS: 0.12 ± 0.01; Fig. 5e). This was in line with the concomitant increase of the number of spikes participating in bursts and NB (Fig. 5f, Supplementary Fig. 8b,c). Since GABA in BENOs switched from excitatory to inhibitory between IS and LS, we compared other properties at these two stages. Although the burst and NB frequency was unchanged (0.1 Hz) the mean interspike interval (ISI) between burst or NB significantly decreased in LS BENOs to 20 ms and 2 ms, respectively (Fig. 5f). In addition, the NB duration significantly increased with time (Supplementary Fig. 8e). These data demonstrate accelerated formation of complex networks of excitatory and inhibitory neurons in BENOs.
BENOs present electrically induced neuronal plasticity
Since three of the five most significant GO groups upregulated in BENOs were associated with synaptic plasticity and long-term synaptic potentiation (GO:0048167; GO:0060291 GO:0048168, Supplementary Data 1), we next assessed BENO neuronal plasticity by investigating paired-pulse depression (PPD) as well as short- and long-term potentiation and depression (STP/D and LTD/P). To test for PPD, we stimulated LS BENOS by a bipolar electrode and observed calcium activity of neurons located 200 µm away from the stimulation electrode (Fig. 6a). Paired-pulse stimulation resulted in depression of calcium activity of every second pulse (Fig. 6b–d). Since one of the mechanisms underlying PPD observed in the hippocampus is mediated by presynaptic GABA release21, we repeated the stimulation under GABA-receptor blockade with PTX. PPD was alleviated by PTX and re-appeared upon washout, providing evidence for presynaptic GABA release involvement in the observed PPD (Fig. 6b–d, Supplementary Fig. 9a, b depicts detailed traces from two independent BENOs). Another typical form of plasticity observed in the hippocampus and associated with learning22 is potentiation or depression of neuronal signal in response to HFS22. To test whether BENOs contain neurons which can demonstrate LTP/D, STP/D as signs for plasticity, 300 µm slices (from n = 6 BENOs) were placed on MEAs for monitoring of electrical activity (Supplementary Fig. 9c). BENOs were stimulated with single pulses (100 µA, 100 µs pulse width, 30 s inter-pulse interval) until signals were stable and then three pulses of HFS (60 µA, 100 Hz) were delivered. After HFS, electrical signals were recorded for 1 h. Electrodes with a >15% signal increase from baseline indicated potentiation; electrodes with >15% signal decrease from baseline indicated depression (representative traces in Fig. 6f). Evidence for potentiation and depression could be obtained in all investigated BENOs (n = 6; Fig. 6g), demonstrating that plasticity is a fundamental property of maturing BENOs.
Until recently, studies on human brain development were limited to rare human fetal brain material23. Emerging organoid technologies provide human neuronal cell culture models, which recapitulate in some aspects embryonic brain with cortical layer development2,7,24. These 3-dimensional cultures typically rely on neuronal induction in pluripotent stem cell cultures, i.e., typically human embryonic or induced pluripotent stem cell cultures, and subsequent embedding of the differentiated neuronal progenitors in laminin-rich Matrigel™1,2,3,5,6,8, which is well known for being supportive in neuronal cell culture25. Alternative cell aggregation models, referred to as cortical spheroids, are developed without the need for the addition of a matrix4,7,9. Organoid and spheroid models have been extensively studied as to cell content1,2,3,4,5,6,7,8 and directed to develop into distinct brain structures4,5,6. Electrophysiological analyses documented consistently that individual neurons in organoids/spheroids maintain their autonomous function7,8. Network formation, being essential for complex brain function, has not yet been characterized in detail in brain organoids, but appears to occur in some models after 9 months8. In a recent elegant spheroid study, network oscillations were demonstrated after 7 months9. Here, we demonstrate complex network function of the developing (GDP) and the more mature (LTP) human brain after 2 months of BENO culture. Evidence for plasticity underlying learning and memory are in our view particularly exciting as the basis for future exploitation of BENOs in drug development targeting the underlying mechanisms.
BENO development can be divided in four distinct stages: (1) d3–15 commitment to NPC, (2) d15–28 neurogenesis, (3) from d28 onwards neuronal maturation, which is (4) supported by gliogenesis from day 50 onwards. These stages appear to resemble fetal brain development, where neurogenesis precedes gliogenesis. During gliogenesis astrocytes, outer radial glia, and oligodendrocytes developed, with concomitant synaptic maturation, in line with in vivo data26. It is important to note that BENOs after d90 contained increasing numbers of myelinated axons comparable to published protocols designed to support cortical spheroid myelination27.
Synaptogenesis coincides during development with neuronal connectivity and network formation. To test the hypothesis that BENOs may serve as a model to study and understand neuronal network formation and maturation, we utilized calcium imaging and MEA analyses for longitudinal studies and found similar network activity dynamics in BENOs as reported for the fetal brain. Studies in mouse and human fetal brain, showed that a hallmark of neuronal network development is the presence of GDPs11. The TTX-sensitive GDPs are GABA and glutamate dependent11 and have been shown to be initiated by pioneer GABAergic somatostatin (SST) positive cells of the hippocampus known as hub neurons12. During fetal development GDP frequency initially increases, then decreases and then it ceases completely in early postnatal life13,14,15,28. Similar to the fetal brain, BENOs present TTX-sensitive GDP-like events, which are GABA and glutamate dependent. The GDP-like event frequency increases between day 25 and 40, but significantly decreases in later stages. After culture day 40, no GDP-like events were recorded. However, we cannot exclude that GDPs may still occur at very low frequency. BENO transcriptome profiling showed enrichment of hippocampal neuronal markers, including SST, between days 28 and 40. Future experiments based on genetic tracing of SSTpos neurons in combination with calcium imaging may help to identify the specific mechanisms underlying GDP, which includes the investigation whether GABApos SSTpos hub neurons12 initiate the GDP-like events. Although we did not systematically examine BENOs for parvalbumin positive GABAergic neurons, the transcriptomic data show a small increase at d60, thus suggesting that it is a matter of time for this population to emerge. A more systematic analysis, including single cell sequencing in d90 organoids should be performed in the future in order to fully appreciate the dynamics of BENO cellular complexity.
Another hallmark of neuronal network maturation is the switch of excitatory to inhibitory GABAergic neurotransmission29. Interestingly, the disappearance of GDP-like events in BENOs coincided with the switch of GABA from excitatory to inhibitory. In contrast to BENOs, 2D cultures of iPSC-derived forebrain neurons show GDP-like events at low frequency only after prolonged culture (d58 in 2D vs d22 in ES BENOs) and a peak of GDP-activity by d70 in 2D culture (vs d35 in IS BENO culture). Reduction in GDP was reported after d100 in 2D (vs d40 LS BENOs)17. The 2D forebrain cultures contained few GABAergic neurons and thus their contribution to GDP-like events could not be demonstrated17. Although no GDP events were previously demonstrated in an organoid level, Sakaguchi et al. showed that 109d-old neurons (deriving from dissociated brain organoids) exhibit local calcium networks bursts30. They further revealed that these areas contained both glutamatergic and GABAergic neurons. These data are in agreement with our findings and underline the importance of inhibitory neurons for comprehensive network formation. The expedited neuronal development in BENOs was further evidenced by the observation of features indicating network complexity after 2 months in culture, whereas similar features have been reported recently in other brain organoid models after 7 months in culture9. In both studies the network complexity increased in the presence of inhibitory GABAergic neurons (2 months in BENOs vs 6-10 months in cortical spheroids9). Our data, in line with the recent data from the Muotri group9 underscore the requirement of inhibitory GABAergic neurotransmission for neuronal network maturation in brain organoids.
Another hallmark of network function is neuronal plasticity. Our study identified phenomena associated with neuronal plasticity being present in BENOs, such as PPD and STP/D and LTP/D. PPD, a typical form of plasticity observed in the hippocampus, is explained by presynaptic mechanisms, such as neurotransmitter depletion or postsynaptic mechanisms21. In BENOs, the observed PPD was mediated by postsynaptic inhibitory GABAergic neurons since GABA-A receptor blockade could completely abrogate this phenomenon. These data demonstrate the importance of interneurons in plasticity and complex network function. Interestingly, evolutionary studies have shown that the amount of interneurons in primates is much higher than rodents (40% vs 20% of cortical neurons respectively, see review)31. LTP is a typical electrophysiological feature of plasticity, which is observed in the hippocampus and is the underlying mechanism for learning and memory. In mouse hippocampal slices LTP is measured after HFS32. Similarly, 1 h upon HFS, electrical network activity in BENOs demonstrated long- and short-term potentiation or depression, providing evidence for stimulus entrained plasticity in a human brain organoid model.
Although, brain organoids represent useful models to study brain development, cellular heterogeneity and limited network function are considered key caveats. Transcriptional and protein profiles in BENOs suggested the presence of glutamatergic, GABAergic, catecholaminergic, and serotinergic neurons as well as myelinating (oligodendrocytes) and non-myelinating (astrocytes) glia. BENOs traverse through distinct phases of development with primitive network function (GDP) and more advanced network function (PPD and LTP/D), which requires the interplay of excitatory (glutamatergic) and inhibitory (GABAergic) neurons. Our data suggest that the use of brain organoids in developmental or drug discovery studies has to carefully consider their developmental stage to address specific pathophysiologically relevant questions. The development of a natural cellular composition (e.g., excitatory and inhibitory neurons) and the definition of the state of electrophysiological maturation (day 25 vs 50 in BENOs with little and consistent network activity, respectively) are important factors when designing drug discovery experiments, for example in the context of epilepsy.
BENO generation (protocol 5)
The GMP hiPS line (TC1133, Lonza)33 and an in-house generated line (hiPS-G1)34 were used for BENO generation. The BENO differentiation protocol was established using the hiPS-G1 reference line. Immunofluorescence analyses and the functional data were replicated in both lines to test for protocol robustness. One day prior to neuronal differentiation, a 1:1 mixture of acid-solubilized bovine collagen I (Collagen Solutions) and serum free 2× DMEM (Thermoscientific) was prepared and neutralized by 0.1 M NaOH addition. iPSC suspensions (4500 cells/µl) were prepared in StemMACS™ iPS-Brew XF medium (Miltenyi) complemented with 20 ng/ml of FGF-2 (Miltenyi) and 10 µmol/L Y-27632 (Stemgent). iPSCs were added to the collagen/DMEM mixture to achieve a final concentration of 3,000 cells/µl and 1 mg/ml of collagen I. Thirty microliters of cell-collagen mixtures was aliquoted into 96-well plates (U-bottom, low attachment) and placed in an incubator for 30 min. Upon collagen polymerization, 250 µl of StemMACS™ iPS-Brew XF supplemented with 10 ng/ml FGF and 10 µmol/L Y-27632 were added in each well. From day 0 to 10 BENOs were cultured in neuronal commitment medium (NCM, Basal medium [Neurobasal-A containing 2 mmol/L glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 2% B27, 1% N2 supplement, 200 µmol/L ascorbic acid] complemented with 10 µmol/L SB 431542 [Tocris], 50 ng/ml noggin [R&D systems] and 1 µmol/L RA [Sigma]). On day 3, BENOs were transferred into six-well plates (10 BENOs/well). From day 10 to 15 BENOs were cultured in neural progenitor expansion medium (NPEM, Basal medium complemented with 10 ng/ml FGF-2 and 5 ng/ml TGFB1 [Peprotech]). Finally, from day 15 to 28 BENOs were cultured in Neural Differentiation Medium (Basal medium complemented with 2.5 µmol/L DAPT [Tocris] and 5 ng/ml TGFB1). From day 29 and until the day of analysis, BENOs were cultured in Basal medium. Medium change was performed every second day. BENO preparation protocols 1–4 were modified as depicted in Fig. 1a. Note that large quantities of BENOs can be generated in parallel with highly reproducible morphology (Supplementary Fig. 1e). A step-by-step protocol describing the generation of BENOs can be obtained from Nature Protocol Exchange35.
For calcium analysis, whole BENOs were loaded for 15–30 min with 1 µg/ml Fluo-8-AM in carbogenated artificial cerebrospinal fluid (ACSF) buffer (mmol/L: 26 NaHCO3, 10 dextrose, 1 MgSO4·7H2O, 1.25 NaH2PO4, 2.5 KCl, 126 NaCl, 2 CaCl2), pH 7.3. Calcium imaging was performed on a confocal microscope (Zeiss LSM 780 equipped with ZEN 2010 software), while BENOs were continuously perfused with ACSF and the temperature was maintained at 37 °C. Fluorescence was recorded at 2–5 Hz whilst electrical stimulation was given at a defined time with five pulses (50 µs, 50–100 µA) with ISI 75 ms every 2 s. Action potential mediated calcium activity was blocked by 1 µmol/L TTX (final concentration) for 1 min and reperfusion with ACSF. Similarly, GABA-B receptors were blocked by 330 µmol/L Saclofen (Tocris), GABA-A and -C receptors were blocked by 58 µmol/L Picrotoxin (PTX; Sigma), NMDR by 0.2 µmol/L (+)-MK-801 hydrogen maleate (Sigma) and AMPAR by 15 µmol/L CNQX (Sigma). Activation of the GABAergic or the glutamatergic network was achieved by 10 µmol/L GABA (Sigma) or 10 µmol/L Glutamic acid (Sigma) respectively. Automated synchronization detection was performed using Matlab R2012a (The Math Works, USA).
Na and K currents were recorded by conventional whole-cell patch-clamping. BENO slices were stained with Fluo-8-AM as described above. Ca-activity was visualized with an upright microscope (Zeiss LSM 780 equipped with ZEN 2010 software). Patch pipettes (2–4 MΩ) were pulled from borosilicate glass (1.6 mm outside diameter) and filled with intracellular solution containing (in mmol/L): 135 HMeSO4, 10 KCl, 1 EGTA, 10 HEPES, 2 MgCL2, 2 ATP-Na2, 0.1 GTP-Na, 6.6 Phosphocreatine-Na2, with pH adjusted to 7.2–7.4 by KOH, and osmolarity adjusted to 290–295 mOsm. Membrane currents were elicited by a series of depolarizing pulses between −60 mV and +50 mV, in 10 mV increments, from a holding potential of −70 mV. An EPC-9 patch-clamp amplifier equipped with Patchmaster software (HEKA Electronics, Germany) was used for data acquisition. Liquid-junction potentials, leak currents (P/n protocol), fast and slow capacitances36,37, and series resistances were corrected on-line. The data were sampled at 20 kHz and filtered at 10 kHz (four-pole Bessel) and 5.9 kHz (three-pole Bessel). Data were stored and exported to Matlab (The Math Works, USA) for subsequent analyses.
Six-well plates with 64 platinum microelectrodes arrays per well (MEA; 0.04 MΩ/microelectrode, 30 µm microelectrode diameter, 200 µm spacing) were coated with Matrigel™ 1:120 diluted in PBS for 1 h at room temperature prior seeding. One or two slices (thickness: 300 µm) were placed into a MEA well and immobilized by a concentrically coiled tungsten ring. 10–15 min recordings/2 h were performed every other day for up to 60 days using a Maestro pro MEA system (Axion Biosystems). Data recordings were automatically scheduled with the Axion Software (AxIS Navigator) using the manufacturer’s Spontaneous Neural Configuration. Data analysis was performed using the manufacturer’s standalone tools, Neural Metric Tool, and AxIS Metric Plotting Tool (Axion Biosystems). The spike detecting threshold was set to 5.5 standard deviations, and the electrodes that detected at least 5 spikes per min were classified as active. Spike bursts were identified using an ISI threshold requiring a minimum number of five spikes with a maximum ISI of 100 ms. NB were identified by an envelope algorithm with a threshold of 1.25, minimum IBI interval of 100 ms, 75% burst inclusion with a minimum of 10% active electrodes. Firing synchrony was estimated by the area under the normalized synchrony cross-correlogram for a time window of 20 ms.
For potentiation measurements, multi-channel fEPSP recordings were performed with a MEA2100 device (MC_Rack 22.214.171.124 software, Multi Channel Systems, Reutlingen, FRG). To reduce noise, the bath was grounded via an extra custom-made Ag/AgCl electrode attached to the MEA amplifier ground socket. LTP was induced by 3 trains of HFS (20 pulses 100 Hz, 50 µs, 100 µA) in 20 s interval. Prior to HFS, neurons were stimulated by single pulses (100 µA, 50 µs pulse width, 30 s inter-pulse interval). After stimulation the same protocol was performed for 1 h in order to quantify differences in synaptic strength.
Wholemount immunofluorescence (WmIF)
BENOs were fixed with 4% formaldehyde solution (Histofix, Carlroth) for 2 h at 4 °C. Subsequently, they were washed twice with PBS and blocked for 30 min at 4 °C with staining buffer (StB; 5% FBS, 1% BSA, 0,5% Triton X-100 in PBS). BENOs were incubated with primary antibodies diluted in StB for 2 days at 4 °C (100 µl/BENO). Upon washing with StB for 6–8 h, BENOs were incubated with secondary antibodies and Hoechst 33342 (Sigma) for another 2 days at 4 °C. After StB washings for a total of 6–8 h BENOs were mounted on glass coverslips. An antibody list with respective dilutions is provided in Supplementary Data 2. WmIF was visualized using confocal imaging performed on a Zeiss LSM 710 confocal microscope equipped with ZEN 2010 software.
RNA extraction and quantitative PCR
RNA was extracted from BENOs with the NucleoSpin RNA isolation kit (Macherey‐Nagel), according to the manufacturer’s instructions. Reverse transcription was performed using Oligo(dT)20 primer (Eurofins Genomics), dNTP mix and M‐MLV reverse transcriptase (Promega). For qPCR analysis SYBR Green (Promega and Eurogentec) and a 7900 HT Fast real‐time PCR system (Applied Biosystems) were used. qPCR data were collected and analyzed by SDS2.4 software (Applied Biosystems). Primer sequences are provided in Supplementary Data 3.
RNA was isolated using the Macherey-Nagel RNA isolation kit (cat. no. 740955). RNA integrity was verified by Agilent Bioanalyzer 2100. The cDNA library was prepared from 100 ng of total RNA, by TruSeq Stranded Total RNA Sample Prep (Illumina) according to the manufacturer’s instructions. Briefly, total RNA was depleted from ribosomal RNA by magnetic bead separation. Ribodepleted RNA was fragmented and first strand synthesis was performed. Second strand synthesis was performed using dUTP so that at the PCR amplification step only the first strand was amplified. Prepared libraries were quantified using the Qubit High Sensitivity Assay (Invitrogen), the size distribution was controlled using Bioanalyzer 2100 and sequencing was performed using HiSeq2000 (SR 50 bp) according to the manufacturer’s instructions. Bcl files were demultiplexed and converted to fastq using fastq2bcl. Fastq files were mapped using TopHat (v2.1.1) and fragments per kilobase of transcript per million (FPKM) calculated using Cufflinks (v2.2.1)38. Only protein coding transcripts were considered for further analysis. Human genome annotation used was GRCh38.87. All genes with FPKM < 1 were omitted for the respective data sets for Fig. 2. Differential gene expression was performed using Cuffdiff39. GO analysis was performed by ClueGo plugin (v2.5.1)40 in cytoscape (v3.6.1)41. The visualization of data was done in R.
All data are displayed as mean ± standard error of mean (SEM). The investigated sample number is provided as n. Statistical differences between two groups were tested by two-tailed unpaired Student’s t tests. In case of three and more groups, one-way or two-way ANOVA with appropriate post-hoc testing was performed. The performed statistical tests are specified in the respective figure legends. Statistical significance was assumed if p < 0.05. RNAseq data were corrected according to Benjamini and Hochberg42. For statistical analyses and graphical display of the data Graph Pad Prism (GraphPad Software) was used.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The gene array data sets generated in this work have been deposited in Gene Expression Omnibus under the accession number GSE139101. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Bershteyn, M. et al. Human iPSC-derived cerebral organoids model cellular features of lissencephaly and reveal prolonged mitosis of outer radial glia. Cell Stem Cell 20, 435–449 e434 (2017).
Qian, X. et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165, 1238–1254 (2016).
Watanabe, M. et al. Self-organized cerebral organoids with human-specific features predict effective drugs to combat zika virus infection. Cell Rep. 21, 517–532 (2017).
Birey, F. et al. Assembly of functionally integrated human forebrain spheroids. Nature 545, 54–59 (2017).
Monzel, A. S. et al. Derivation of human midbrain-specific organoids from neuroepithelial stem cells. Stem Cell Rep. 8, 1144–1154 (2017).
Bagley, J. A., Reumann, D., Bian, S., Levi-Strauss, J. & Knoblich, J. A. Fused cerebral organoids model interactions between brain regions. Nat. Methods 14, 743–751 (2017).
Pasca, A. M. et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671–678 (2015).
Quadrato, G. et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545, 48–53 (2017).
Trujillo, et al. Complex oscillatory waves emerging from cortical organoids model early human brain network development. Cell Stem Cell 25, 558–569.e7 (2019).
Robinson, H. P. et al. Periodic synchronized bursting and intracellular calcium transients elicited by low magnesium in cultured cortical neurons. J. Neurophysiol. 70, 1606–1616 (1993).
Lombardi, A., Jedlicka, P., Luhmann, H. J. & Kilb, W. Giant depolarizing potentials trigger transient changes in the intracellular Cl(-) concentration in CA3 pyramidal neurons of the immature mouse hippocampus. Front Cell Neurosci. 12, 420 (2018).
Picardo, M. A. et al. Pioneer GABA cells comprise a subpopulation of hub neurons in the developing hippocampus. Neuron 71, 695–709 (2011).
Moore, A. R., Zhou, W. L., Jakovcevski, I., Zecevic, N. & Antic, S. D. Spontaneous electrical activity in the human fetal cortex in vitro. J. Neurosci. 31, 2391–2398 (2011).
Moore, A. R. et al. Connexin hemichannels contribute to spontaneous electrical activity in the human fetal cortex. Proc. Natl Acad. Sci. USA 111, E3919–E3928 (2014).
Tolonen, M., Palva, J. M., Andersson, S. & Vanhatalo, S. Development of the spontaneous activity transients and ongoing cortical activity in human preterm babies. Neuroscience 145, 997–1006 (2007).
Araque, A. & Navarrete, M. Glial cells in neuronal network function. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365, 2375–2381 (2010).
Kirwan, P. et al. Development and function of human cerebral cortex neural networks from pluripotent stem cells in vitro. Development 142, 3178–3187 (2015).
Stipursky, J. et al. Corrigendum: TGF-beta1 promotes cerebral cortex radial glia-astrocyte differentiation in vivo. Front Cell Neurosci. 9, 232 (2015).
Crawford, T. Q. & Roelink, H. The notch response inhibitor DAPT enhances neuronal differentiation in embryonic stem cell-derived embryoid bodies independently of sonic hedgehog signaling. Dev. Dyn. 236, 886–892 (2007).
Long, K. R. et al. Extracellular matrix components HAPLN1, lumican, and collagen I cause hyaluronic acid-dependent folding of the developing human neocortex. Neuron 99, 702–719 e706 (2018).
Kirischuk, S., Clements, J. D. & Grantyn, R. Presynaptic and postsynaptic mechanisms underlie paired pulse depression at single GABAergic boutons in rat collicular cultures. J. Physiol. 543, 99–116 (2002).
Neves, G., Cooke, S. F. & Bliss, T. V. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 9, 65–75 (2008).
Espuny-Camacho, I. et al. Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77, 440–456 (2013).
Lancaster, M. A. et al. Guided self-organization and cortical plate formation in human brain organoids. Nat. Biotechnol. 35, 659–666 (2017).
Jucker, M., Kleinman, H. K. & Ingram, D. K. Fetal rat septal cells adhere to and extend processes on basement membrane, laminin, and a synthetic peptide from the laminin A chain sequence. J. Neurosci. Res. 28, 507–517 (1991).
Baldwin, K. T. & Eroglu, C. Astrocytes “Chordinate” synapse maturation and plasticity. Neuron 100, 1010–1012 (2018).
Madhavan, M. et al. Induction of myelinating oligodendrocytes in human cortical spheroids. Nat. Methods 15, 700–706 (2018).
Corlew, R., Bosma, M. M. & Moody, W. J. Spontaneous, synchronous electrical activity in neonatal mouse cortical neurones. J. Physiol. 560, 377–390 (2004).
Ganguly, K., Schinder, A. F., Wong, S. T. & Poo, M. GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell 105, 521–532 (2001).
Sakaguchi, H. et al. Self-organized synchronous calcium transients in a cultured human neural network derived from cerebral organoids. Stem Cell Rep. 13, 458–473 (2019).
Mostajo-Radji, M. A., Schmitz, M. T., Montoya, S. T. & Pollen, A. A. Reverse engineering human brain evolution using organoid models. Brain Res. 1729, 146582 (2020).
Wang, M., Ramasamy, V. S., Samidurai, M. & Jo, J. Acute restraint stress reverses impaired LTP in the hippocampal CA1 region in mouse models of Alzheimer’s disease. Sci. Rep. 9, 10955 (2019).
Baghbaderani, B. A. et al. cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications. Stem Cell Rep. 5, 647–659 (2015).
Tiburcy, M. et al. Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair. Circulation 135, 1832–1847 (2017).
Zafeiriou, M.-P., Bao, G., Blenkle, A., Schreiber, M.-K. & Zimmermann, W.-H. Generation of bioengineered neuronal organoids (BENOs) from human pluripotent stem cells. Nature Protocol Exchange https://doi.org/10.21203/rs.3.pex-998/v1 (2020).
Sigworth, F. J. Design of the EPC-9, a computer-controlled patch-clamp amplifier. 1. Hardware. J. Neurosci. Methods 56, 203–215 (1995).
Sigworth, F. J., Affolter, H. & Neher, E. Design of the EPC-9, a computer-controlled patch-clamp amplifier. 2. Software. J. Neurosci. Methods 56, 203–215 (1995).
Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511–515 (2010).
Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46–53 (2013).
Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091–1093 (2009).
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).
The authors would like to especially thank Reinhard Jahn and Laura Zelarayan for the scientific discussions as well as Krasimira Sharkova, Petra Tucholla, Cheila Rocha, Kea Schmoll, and Lennart Schneider for the excellent technical assistance. M.P.Z., A.F., and W.H.Z. are supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy—EXC 2067/1-390729940. J.E.H. is funded by the NHMRC (National Health and Medical Research Council) of Australia. W.H.Z. is supported by the DZHK (German Center for Cardiovascular Research) and the German Research Foundation (DFG ZI 708/10-1, SFB 1002 C04, S01). A.F. is supported by the DZNE (German Center for Neurodegenerative Diseases), the ERC consolidator grant DEPICODE (648898), and the DFG (SFB1002 D04 and SFB1286 B06). Generation of the GMP line LiPSC-GR1.1 (also referred to as TC1133; lot number 50-001-21) was supported by the NIH Common Fund Regenerative Medicine Program, and reported in Stem Cell Reports. The NIH Common Fund and the National Center for Advancing Translational Sciences (NCATS) are joint stewards of the LiPSC-GR1.1 resource. We acknowledge support by the Open Access Publication Funds of the Göttingen University. All authors have approved the submitted version and agreed both to be personally accountable for the author’s own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.
The University Medical Center Göttingen has filed a patent covering production and applications of the BENO technology (WO2018228948A1). M.P.Z. and W.H.Z are listed as inventors of the BENO technology. myriamed GmbH has licensed the BENO technology for applications in drug development. W.H.Z. is co-founder and equity holder of myriamed GmbH. The remaining authors declare no competing interests.
Peer review information Nature Communications thanks Mohammed Mostajo-Radji and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zafeiriou, MP., Bao, G., Hudson, J. et al. Developmental GABA polarity switch and neuronal plasticity in Bioengineered Neuronal Organoids. Nat Commun 11, 3791 (2020). https://doi.org/10.1038/s41467-020-17521-w
Nature Biomedical Engineering (2022)
Brain organoid: a 3D technology for investigating cellular composition and interactions in human neurological development and disease models in vitro
Stem Cell Research & Therapy (2021)
3D high-density microelectrode array with optical stimulation and drug delivery for investigating neural circuit dynamics
Nature Communications (2021)